PPARG and ovarian cancer: Although several reports indicate that different cell lines respond differently to TZDs, [30], [31], [32], [33], to our knowledge, a direct comparison between these four TZDs in ovarian cancer and delineating whether these effects are PPARγ dependent using molecular, physiological and pharmacological approaches has not been investigated.